Medicament for treating dysentery

Abstract

The invention relates to a medicament for treating dysentery. The medicament is characterized by comprising the following components in parts by weight: 20-30 parts of angelica sinensis, 15-25 parts of coptis chinensis, 8-16 parts of elecampane, 6-12 parts of eclipta alba, 10-16 parts of herba portulacae, 5-10 parts of humifuse euphorbia herb, 4-8 parts of duckweed, 15-25 parts of radix paeoniae alba, 4-8 parts of plant soot, 5-10 parts of scutellaria baicalensis, 2-6 parts of herba pteridis multifidae, 3-7 parts of Syzygium jambos, 10-16 parts of root of barnyard grass, 10-20 parts of root of Chinese pulsatilla, 12-18 parts of bark of ash and 6-12 parts of sessile alternanthera herb. The medicament has the beneficial effects that that 1, taking by children and adults is facilitated; 2, the medicament is quick to take effect and quick to treat; 3, the medicament is large in dispersity, quick to absorb and quick to take effect; 4, the medicament is even in effective components, high in availability and thorough to treat; 5, the medicament is good in taste, convenient to take and excellent in urgent need; 6, the medicament also contains essential amino-acids which cannot be synthesized by a human body, vitamins, enzymes of helping digestion, and microelements.

Description

technical field [0001] The invention relates to a medicine for treating dysentery. Background technique [0002] At present, for children and adults with damp-heat dysentery, abdominal pain, diarrhea; pyretic bloody dysentery, amoebic dysentery, bacillary dysentery, hematuria, blood in the stool, and concurrent pulmonary heat cough, fever, sore throat and other diseases are generally treated with antibiotics , or continue to use the compatible decoction of the doctors of the past dynasties. However, the human body will be resistant to antibiotics, and after long-term use, it will not be able to effectively kill germs. At the same time, due to the resistance of antibiotics, patients often need to continuously increase the dose of antibiotics or replace new types of antibiotics during the use of antibiotics, which greatly increases the cost of research and development and the economic burden of patients. Moreover, there may be a situation where no medicine is available. The...

AI Technical Summary

Problems solved by technology

However, the human body will be resistant to antibiotics, and after long-term use, it will not be able to effectively kill germs

At the same time, due to the resistance of antibiotics, patients often need to continuously increase the dose of antibiotics or replace new types of antibiotics during the use of antibiotics, which greatly increases the cost of research and development and the economic burden of patients

Moreover, there may be a situation where no medicine is available